scholarly journals Donor cell-derived transient abnormal myelopoiesis as a specific complication of umbilical cord blood transplantation

2017 ◽  
Vol 53 (2) ◽  
pp. 225-227
Author(s):  
N Hiramoto ◽  
J Takeda ◽  
K Yoshida ◽  
Y Ono ◽  
S Yoshioka ◽  
...  
Blood ◽  
2010 ◽  
Vol 116 (4) ◽  
pp. 649-652 ◽  
Author(s):  
Shinsuke Takagi ◽  
Yasunori Ota ◽  
Naoyuki Uchida ◽  
Koichi Takahashi ◽  
Kazuya Ishiwata ◽  
...  

Abstract Although allogeneic hematopoietic stem cell transplantation has recently been applied to patients with myelofibrosis with reproducible engraftment and resolution of marrow fibrosis, no data describe the outcomes of umbilical cord blood transplantation. We describe 14 patients with primary (n = 1) and secondary myelofibrosis (n = 13) who underwent reduced-intensity umbilical cord blood transplantation. Conditioning regimens included fludarabine and graft-versus-host disease prophylaxis composed cyclosporine/tacrolimus alone (n = 6) or a combination of tacrolimus and mycophenolate mofetil (n = 8). Thirteen patients achieved neutrophil engraftment at a median of 23 days. The cumulative incidence of neutrophil and platelet engraftment was 92.9% at day 60 and 42.9% at day 100, respectively. Posttransplantation chimerism analysis showed full donor type in all patients at a median of 14 days. The use of umbilical cord blood could be feasible even for patients with severe marrow fibrosis, from the viewpoint of donor cell engraftment.


2005 ◽  
Vol 27 (9) ◽  
pp. 462
Author(s):  
Christopher J Fraser ◽  
Betsy A Hirsch ◽  
Vanessa Dayton ◽  
Joseph P Neglia ◽  
John E Wagner ◽  
...  

Author(s):  
Stephanie Vairy ◽  
Isabelle Louis ◽  
Marie-France Vachon ◽  
Johanne Richer ◽  
Pierre Teira ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document